| Serial Number | 98256227 |
| Word Mark | LIQUI SRS |
| Filing Date | Monday, November 6, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, April 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 11, 2025 |
| Goods and Services | Pharmaceutical drugs for the treatment and prevention of chronic and non-chronic diseases, namely, pain diseases, cardiovascular diseases, cancer diseases, infectious diseases, neural diseases, respiratory diseases, obesity diseases, and kidney diseases; Drug delivery agents in particular sustained release agents in the form of capsules and tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drugs for medical for purposes in particular sustained release drug formulations for the treatment and prevention of chronic and non-chronic diseases, namely, pain diseases, cardiovascular diseases, cancer diseases, infectious diseases, neural diseases, respiratory diseases, obesity diseases, and kidney diseases |
| Goods and Services | Drug discovery services; biological research; clinical research in the medical, pharmaceutical, and biotechnology fields; medical research; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the pharmaceutical and biotechnology fields for the pharmaceutical industry; pharmaceutical products development; pharmaceutical formulation in the nature of pharmaceutical products development; biomedical research services; medical and scientific research in the field of pharmacogenetics; research and development of vaccines and medicines; pharmaceutical drug development services; development of pharmaceutical preparations in particular sustained release formulations and medicines; pharmaceutical research services. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 30, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 30, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EMOVIAR PharmaCon GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | D-79664 Wehr 79664 DE |
| Party Name | EMOVIAR PharmaCon GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | D-79664 Wehr 79664 DE |
| Event Date | Event Description |
| Thursday, November 9, 2023 | NEW APPLICATION ENTERED |
| Thursday, November 30, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 14, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, June 26, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, July 31, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 31, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 26, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 26, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 31, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 18, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 18, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, December 6, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 6, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 18, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 6, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 22, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 8, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 11, 2025 | PUBLISHED FOR OPPOSITION |
| Monday, July 7, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, July 7, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, July 7, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, July 7, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, July 7, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Monday, July 7, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 7, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |